XML 27 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

(12) Stockholders’ Equity

The following table shows changes in the number of shares of our outstanding common stock:

 

 

Nine months ended September 30,

 

 

 

2025

 

 

2024

 

 

 

(In thousands)

 

Common stock, beginning of period

 

 

33,368

 

 

 

34,996

 

Shares of common stock issued when sales restrictions on restricted stock units
   (“RSUs”) lapsed and performance-based stock units (“PSUs”) were earned

 

 

120

 

 

 

152

 

Common stock retired

 

 

(1,412

)

 

 

(1,640

)

Common stock, end of period

 

 

32,076

 

 

 

33,508

 

 

The above table excludes RSUs, director deferred shares, and PSUs, which do not have voting rights. As sales restrictions on RSUs lapse and PSUs are earned, we issue common shares with voting rights. As of September 30, 2025, we had a total of 206,569 RSUs and director deferred shares outstanding and 44,548 PSUs outstanding. The PSU outstanding balance is based on the number of PSUs granted pursuant to the award agreements; however, the actual number of common shares earned could be higher or lower based on actual versus targeted performance. See Note 14 (Share-Based Transactions) for discussion of the PSU award structure.

On November 14, 2024, our Board authorized, and the Company announced, a share repurchase program for up to $450.0 million of our outstanding common stock for purchases from November 14, 2024 through December 31, 2025 (the “Share Repurchase Program”). Under the Share Repurchase Program, we repurchased 1,381,935 shares of our common stock in the open market for an aggregate purchase price of $376.1 million through September 30, 2025. Approximately $73.9 million remains available for repurchases of our outstanding common stock under the Share Repurchase Program as of September 30, 2025.